E. Ouédraogo

发表

Malaria Incidence in Children in South-West Burkina Faso: Comparison of Active and Passive Case Detection Methods

S. Sirima, A. Rehman, P. Milligan, 2014, PloS one.

Assessment of Recovery Time, Worsening, and Death among Inpatients and Outpatients with COVID-19, Treated with Hydroxychloroquine or Chloroquine plus Azithromycin Combination in Burkina Faso

H. Tinto, I. Valéa, T. Rouamba, 2022, International Journal of Infectious Diseases.

Intermittent Preventive Treatment of Malaria Provides Substantial Protection against Malaria in Children Already Protected by an Insecticide-Treated Bednet in Burkina Faso: A Randomised, Double-Blind, Placebo-Controlled Trial

S. Cousens, D. Chandramohan, S. Sirima, 2011, PLoS medicine.

Morbidity from Malaria in Children in the Year after They Had Received Intermittent Preventive Treatment of Malaria: A Randomised Trial

S. Cousens, D. Chandramohan, B. Greenwood, 2011, PloS one.

Seasonal performance of a malaria rapid diagnosis test at community health clinics in a malaria-hyperendemic region of Burkina Faso

S. Sirima, A. Gansané, I. Soulama, 2012, Parasites & Vectors.

Haematological parameters, natural regulatory CD4 + CD25 + FOXP3+ T cells and γδ T cells among two sympatric ethnic groups having different susceptibility to malaria in Burkina Faso

S. Sirima, M. Torcia, D. Modiano, 2012, BMC Research Notes.

Safety and Immunogenicity of the Malaria Vaccine Candidate MSP3 Long Synthetic Peptide in 12–24 Months-Old Burkinabe Children

S. Cousens, S. Sirima, Y. Kaboré, 2009, PloS one.

Anti-malarial efficacy and resistance monitoring of artemether-lumefantrine and dihydroartemisinin-piperaquine shows inadequate efficacy in children in Burkina Faso, 2017–2018

H. Tinto, I. Valéa, D. Ménard, 2021, Malaria journal.

Safety and immunogenicity of a recombinant Plasmodium falciparum AMA1-DiCo malaria vaccine adjuvanted with GLA-SE or Alhydrogel® in European and African adults: A phase 1a/1b, randomized, double-blind multi-centre trial.

E. Tartour, S. Sirima, F. Batteux, 2017, Vaccine.

Population pharmacokinetics of artesunate and amodiaquine in African children

J. Simpson, S. Sirima, K. Stepniewska, 2009, Malaria Journal.

Malaria Morbidity in High and Seasonal Malaria Transmission Area of Burkina Faso

S. Sirima, A. Gansané, I. Soulama, 2013, PloS one.

Setting Dengue Fever Epidemic Thresholds Between 2016 and 2021 in the Central Health Region, Burkina Faso: An Ecological Study

M. Kaboré, Sylvain Ilboudo, L. Savadogo, 2023, Journal of Epidemiology and Global Health.

A Phase 1b Randomized, Controlled, Double-Blinded Dosage-Escalation Trial to Evaluate the Safety, Reactogenicity and Immunogenicity of an Adenovirus Type 35 Based Circumsporozoite Malaria Vaccine in Burkinabe Healthy Adults 18 to 45 Years of Age

S. Sirima, J. Sadoff, M. Pau, 2013, PloS one.

Incidence rate and predictors of COVID-19 in the two largest cities of Burkina Faso - prospective cohort study in 2021 (ANRS-COV13)

H. Tinto, G. Paradis, T. Kagoné, 2023, BMC Infectious Diseases.

Safety of Chloroquine or Hydroxychloroquine Plus Azithromycin for the Treatment of COVID-19 Patients in Burkina Faso: An Observational Prospective Cohort Study

H. Tinto, I. Valéa, T. Rouamba, 2021, Therapeutics and clinical risk management.

An epidemiological study to assess Plasmodium falciparum parasite prevalence and malaria control measures in Burkina Faso and Senegal

A. Sié, B. Faye, C. Sokhna, 2017, Malaria Journal.